Revolution Medicines, Inc. Warrant (RVMDW)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
8. 40
-1.37
-13.9785%
Pre Market
$
+2.3 +27.381% 10. 70
38.14B Market Cap
- P/E Ratio
- Div Yield
69,531 Volume
- Eps
$ 9.77
Previous Close 
Want to track RVMDW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Revolution Medicines, Inc. Warrant (RVMDW) Statistics
Valuation metrics
Market Cap 38.14B
Enterprise value 37.97B
Trailing P/E (ttm) -20.09
Forward P/E -
PEG ratio 0.36
Price/Sales (ttm) -
Price/Book (mrq) 14.4
Enterprise Value/Revenue -
Enterprise Value/EBITDA -22.46
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 26.57K
Average volume (90 days) 39.91K
Price summary
52-Week low 0.32
52-Week high 13.44
Beta -
50-Day moving average 10.81
200-Day moving average 8
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.41%
Return on equity -0.96%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -8.38
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 18.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 11.38%
Book value per share (mrq) 12.36
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
